Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,804,978
-
Share change
-
+8,211,885
-
Total reported value
-
$1,199,798,993
-
Put/Call ratio
-
196%
-
Price per share
-
$57.67
-
Number of holders
-
115
-
Value change
-
+$492,842,908
-
Number of buys
-
95
-
Number of sells
-
15
Institutional Holders of KITE PHARMA INC - COM (KITE) as of Q4 2014
As of 31 Dec 2014,
KITE PHARMA INC - COM (KITE) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,804,978 shares.
The largest 10 holders included
Capital Research Global Investors, Wildcat Capital Management, LLC, FMR LLC, JPMORGAN CHASE & CO, Capital World Investors, FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., VANGUARD GROUP INC, Capital International Investors, BlackRock Fund Advisors, and SOROS FUND MANAGEMENT LLC.
This page lists
115
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.